Get comprehensive MMP1 gene testing for epidermolysis bullosa dystrophica at only $500 USD. Our NGS genetic DNA test identifies autosomal recessive modifiers to help diagnose and manage this rare skin disorder. Available across major US cities including New York
Get comprehensive ACD Gene Dyskeratosis Congenita Autosomal Recessive Type 7 NGS Genetic DNA Testing for $500 in USA. Advanced NGS technology detects mutations causing bone marrow failure ACD Gene Dyskeratosis Congenita Autosomal Recessive Type 7 Genetic Test Original price was: $700.Current price is: $500.
Get comprehensive LAMA3 Gene Epidermolysis Bullosa testing for $500 USD in USA. Our NGS genetic DNA test detects generalized atrophic benign EB mutations. Available in New York LAMA3 Gene Epidermolysis Bullosa Generalized Atrophic Benign Genetic Test Original price was: $700.Current price is: $500.
Sale!

MMP1 Gene Epidermolysis Bullosa Dystrophica Autosomal Recessive Modifier Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MMP1 Gene Epidermolysis Bullosa Dystrophica Autosomal Recessive Modifier NGS Genetic DNA Test is a specialized diagnostic tool that identifies genetic variations in the MMP1 gene associated with epidermolysis bullosa dystrophica. This comprehensive next-generation sequencing test detects autosomal recessive modifiers that influence disease severity and progression in patients with this rare inherited skin disorder. The test provides crucial information for accurate diagnosis, prognosis assessment, and personalized treatment planning. By analyzing the MMP1 gene’s role in collagen degradation and skin integrity, healthcare providers can better understand disease mechanisms and implement targeted interventions. This advanced genetic testing is available for $500 USD and offers valuable insights for patients and families affected by epidermolysis bullosa.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MMP1 Gene Epidermolysis Bullosa Dystrophica Autosomal Recessive Modifier NGS Genetic DNA Test

Comprehensive Genetic Testing for Epidermolysis Bullosa Dystrophica

The MMP1 Gene Epidermolysis Bullosa Dystrophica Autosomal Recessive Modifier NGS Genetic DNA Test represents a cutting-edge diagnostic approach for individuals affected by or at risk for epidermolysis bullosa dystrophica. This sophisticated genetic analysis utilizes next-generation sequencing technology to identify specific variations in the MMP1 gene that serve as modifiers in autosomal recessive forms of this debilitating skin condition.

Understanding Epidermolysis Bullosa Dystrophica

Epidermolysis bullosa dystrophica is a rare genetic disorder characterized by extreme skin fragility and blister formation in response to minor trauma or friction. The condition results from defects in collagen VII, a crucial protein that anchors the epidermis to the underlying dermis. The MMP1 gene, which encodes matrix metalloproteinase-1, plays a significant role as a modifier gene that can influence disease severity and progression.

What This Test Measures and Detects

Our advanced NGS genetic DNA test specifically targets:

  • Comprehensive analysis of the MMP1 gene sequence
  • Identification of single nucleotide polymorphisms (SNPs)
  • Detection of insertions, deletions, and copy number variations
  • Assessment of genetic modifiers affecting disease expression
  • Evaluation of autosomal recessive inheritance patterns

The test provides detailed information about genetic variations that may modify the clinical presentation of epidermolysis bullosa dystrophica, helping clinicians better predict disease course and tailor treatment strategies.

Who Should Consider This Genetic Test

Clinical Indications and Symptoms

This test is recommended for individuals presenting with:

  • Recurrent skin blistering and erosions from minor trauma
  • Nail dystrophy and loss
  • Mucous membrane involvement affecting oral cavity and eyes
  • Scarring alopecia and milia formation
  • Family history of epidermolysis bullosa or consanguinity
  • Unexplained skin fragility in infancy or childhood
  • Suspected autosomal recessive inheritance pattern
  • Need for genetic confirmation of clinical diagnosis

Significant Benefits of MMP1 Genetic Testing

Undergoing this comprehensive genetic analysis offers numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of epidermolysis bullosa dystrophica
  • Prognostic Information: Helps predict disease severity and potential complications
  • Family Planning: Enables informed reproductive decisions and genetic counseling
  • Personalized Care: Guides targeted treatment approaches based on genetic profile
  • Early Intervention: Facilitates proactive management of potential complications
  • Research Contribution: Advances understanding of genetic modifiers in rare diseases

Understanding Your Test Results

Interpretation Guidelines

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and dermatology specialists:

  • Positive Result: Indicates the presence of MMP1 gene variations that may modify epidermolysis bullosa dystrophica expression
  • Negative Result: Suggests absence of significant MMP1 modifiers in the tested regions
  • Variant of Uncertain Significance: Requires additional family studies or functional analysis
  • Carrier Status: Identifies individuals who may pass genetic variations to offspring

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps for medical management.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Additional Test Information

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Testing Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Dermatology and Genetics
  • Disease Focus: Osteology, Dermatology, Immunology Disorders

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified collection centers ensures accessible genetic testing for patients nationwide.

Take the Next Step Toward Genetic Clarity

If you or a loved one are experiencing symptoms of epidermolysis bullosa dystrophica or have a family history of this condition, our MMP1 genetic test can provide the answers you need. Our team of genetic specialists is ready to guide you through the testing process and help you understand your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic consultation and book your test. Take control of your genetic health with comprehensive, reliable testing from trusted experts in genetic dermatology.

SKU: 4346 Category:

Related products